U.S. market Closed. Opens in 2 hours 6 minutes

RPTX | Repare Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue51.13M131.83M7.60M135.00KN/AN/AN/A
Cost of Revenue1.95M4.18M3.34M1.79M968.00KN/AN/A
Gross Profit49.18M127.65M4.26M-1.65M-968.00KN/AN/A
Operating Expenses163.94M151.63M116.26M54.44M26.38M12.82M6.17M
Selling, General & Admin33.65M32.56M26.21M14.35M5.38M2.91M1.77M
Research & Development130.29M119.07M90.05M40.09M21.00M9.91M4.40M
Other Operating Expenses-119.00K-43.00K-41.00K-16.00K-1.36M-1.14MN/A
Operating Income-114.76M-19.80M-108.66M-54.30M-26.38M-12.82M-6.17M
Other Expenses / Income13.04M5.90M74.00K-440.00K-644.00K-1.43M-1.62M
Before Tax Income-101.72M-13.90M-108.59M-54.74M-27.02M-14.25M-7.80M
Income Tax Expenses-7.92M15.15M-1.68M-1.32M195.00K35.00KN/A
Net Income-93.80M-29.05M-106.91M-53.42M-27.22M-14.28M-7.80M
Interest ExpensesN/A-8.18MN/AN/AN/AN/AN/A
Basic Shares Outstanding42.09M41.92M37.82M36.90M36.67M15.79M15.79M
Diluted Shares Outstanding42.09M41.92M37.82M36.90M36.67M15.79M15.79M
EBITDA-112.81M-20.10M-108.52M-53.64M-26.48M-12.12M-7.69M
EBITDA Margin-220.62%-15.25%-1,427.84%-39,731.85%0.00%0.00%0.00%
EBIT-101.72M-22.08M-108.59M-54.74M-27.02M-14.25M-7.80M
EBIT Margin-198.92%-16.75%-1,428.76%-40,549.63%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙